Chemoinformaics analysis of CYANIDIN-3-GLUCOSYL-RUTINOSIDE
| Molecular Weight | 757.671 | nRot | 9 |
| Heavy Atom Molecular Weight | 716.343 | nRig | 35 |
| Exact Molecular Weight | 757.219 | nRing | 6 |
| Solubility: LogS | -1.375 | nHRing | 4 |
| Solubility: LogP | -1.91 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 94 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 53 | No. of Aromatic Carbocycles | 2 |
| nHetero | 20 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 41 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 20 | No. of Arom Bond | 17 |
| nHA | 19 | APOL | 98.4885 |
| nHD | 13 | BPOL | 53.2835 |
| QED | 0.077 |
| Synth | 5.549 |
| Natural Product Likeliness | 1.567 |
| NR-PPAR-gamma | 0.95 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.981 |
| HIA | 0.996 |
| CACO-2 | -6.421 |
| MDCK | 0.00010791 |
| BBB | 0.289 |
| PPB | 0.795358 |
| VDSS | 0.379 |
| FU | 0.310286 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.01 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.143 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.143 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0 |
| CL | 0.551 |
| T12 | 0.447 |
| hERG | 0.009 |
| Ames | 0.378 |
| ROA | 0.057 |
| SkinSen | 0.022 |
| Carcinogencity | 0.103 |
| EI | 0.006 |
| Respiratory | 0.008 |
| NR-Aromatase | 0.914 |
| Antiviral | Yes |
| Prediction | 0.768383 |